Medical Treatment / Procedure
-
Business
BioNTech Stock Is Falling. Blame it on the prospect of a Covid vaccine.
BioNTech shares fell on Monday despite solid quarterly earnings from the German biotech group. Investors are focused on the company’s…
Read More » -
Business
Novavax Says ‘Significant Doubt’ Around Its Continued Operation
Covid-19 vaccine manufacturer Novavax said on Tuesday that there was “substantial doubt” about its ability to continue operating this year.…
Read More » -
Business
Novavax shares drop by a quarter in value as vaccine maker’s business faces ‘significant doubt’
Shares of Novavax Inc. sank in extended trading on Tuesday after the biotech drugmaker posted more than double losses than…
Read More » -
Business
Moderna shares fall on disappointing earnings, drop in Covid-19 vaccine sales
modern shares fell early Thursday, wiping out gains from positive news surrounding the cancer vaccine candidate, as fourth-quarter earnings fell…
Read More » -
Business
Moderna’s earnings disappoint as sales of Covid-19 vaccines drop
modern shares fell early Thursday, wiping out gains from positive news surrounding the cancer vaccine candidate, as fourth-quarter earnings fell…
Read More » -
Business
Crispr Therapeutics: FDA filing for sickle cell gene therapy almost complete
Filing for approval for a breakthrough sickle cell disease treatment will be made in March Crispr therapy said, highlighting the…
Read More » -
Business
Pfizer CEO: Covid infections will increase. The same goes for Paxlovid and the sale of vaccines.
Pfizer executives said Wall Street analysts didn’t understand how much of an impact the company’s Covid-19 products would have this…
Read More » -
Business
Pfizer reports earnings on Tuesday. What to expect.
When the big pharmaceutical company Pfizer earnings report on Tuesday, before the market opens, all eyes will be on the…
Read More » -
Business
What investors need to know about Pfizer’s latest downgrade
by Pfizer PFE, -0.92% The early-stage pipeline, while promising, is still too early to make up for billions of dollars…
Read More »